GlassScriptPhysician profile
Hans Huenefeld Epp
NPI 1073274304
$1,490.08
in general payments reported to CMS, 2019-2025
24 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $590 · 2024: $559 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $254.06 | 2023-2025 | Mounjaro, Zepbound, Kisunla |
| Abbvie INC. | $197.52 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $141.04 | 2023-2024 | Gemtesa |
| Otsuka America Pharmaceutical, INC. | $116.19 | 2023-2025 | Rexulti |
| Pfizer INC. | $106.25 | 2023-2024 | |
| Novo Nordisk INC | $98.72 | 2023-2025 | Wegovy |
| Exact Sciences Corporation | $67.83 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $67.18 | 2023-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $55.41 | 2023 | Xarelto |
| Dexcom, INC. | $49.19 | 2023 | Dexcom G6 Transmitter |
| Aimmune Therapeutics, INC. | $48.11 | 2024-2025 | Zenpep |
| Shield Therapeutics INC | $42.43 | 2024 | |
| Neurocrine Biosciences, INC. | $39.84 | 2024-2025 | Ingrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.41 | 2023 | |
| Amgen INC. | $23.12 | 2024 | Prolia, Evenity |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $21.92 | 2023 | Nuplazid |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.80 | 2024 | Caplyta |
| Inogen, INC. | $19.19 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Lundbeck LLC | $18.45 | 2024 | Rexulti |
| Nevro Corp. | $18.01 | 2023 | Senza |
| Scilex Pharmaceuticals INC. | $15.48 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $15.39 | 2023 | Austedo Xr |
| Philips North America LLC | $13.59 | 2024 | (Ck7) Extended Holter |
| Lucid Diagnostics INC. | $12.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Epp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.